Efficacy and safety of mycophenolate mofetil in different dosages in Asian renal allograft recipients

By Tsang W.K.   Tong K.L.   Yeung S.   Lee W.   Chan H.W.H.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1755-1756

Elsevier

Access to resources Recommend Favorite

Pharmacoeconomic analysis of mycophenolate mofetil versus azathioprine in primary cadaveric renal transplantation

By Baker G.M.   Martin J.E.   Jang R.   Schroeder T.J.   Armitstead J.A.   Myre S.   First M.R.  

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 4082-4084

Elsevier

Access to resources Recommend Favorite

One-year, single-center cost analysis of mycophenolate mofetil versus azathioprine following cadaveric renal transplantation

By Khosla U.M.   Martin J.E.   Baker G.M.   Schroeder T.J.   First M.R.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 274-275

Elsevier

Access to resources Recommend Favorite

A prospective randomised study of CSA monotherapy versus CSA plus mycophenolate mofetil in cadaveric renal transplant recipients

By Sells R.A.   Bakran A.   Brown M.W.   Grinyo J.   Hammad A.   Hyatt D.   Owens G.  

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 4098-4098

Elsevier

Access to resources Recommend Favorite

Mycophenolate Mofetil (Cellcept) in Renal Transplantation: The European Experience

By European Mycophenolate Mofetil Co-operative Study Group   Garl S.   Wiesel M.  

Transplantation Proceedings, Vol. 29, Iss. 7, 1997-11 ,pp. : 2932-2935

Elsevier

Access to resources Recommend Favorite